Is there a generic for Estrogens, conjugated; meprobamate?

The FDA Orange Book does not currently list an approved generic (ANDA) for Estrogens, conjugated; meprobamate. It is available as 2 brand (NDA) applications.

What is the reference-listed drug for Estrogens, conjugated; meprobamate?

MILPREM-200 (NDA 011045, MEDPOINTE PHARM HLC) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Estrogens, conjugated; meprobamate are approved?

Estrogens, conjugated; meprobamate is approved in the following dosage form: tablet.

FDA Orange Book · active-ingredient family

Estrogens, conjugated; meprobamate

Estrogens, conjugated; meprobamate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:MILPREM-200 · NDA 011045

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · tablet

Product	Applicant	Application	TE	Approved
MILPREM-200×2	MEDPOINTE PHARM HLC	NDA 011045	—	Approved Prior to Jan 1, 1982
PMB 200×2	WYETH AYERST	NDA 010971	—	Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Estrogens, conjugated; meprobamate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo